GPT Healthcare Limited has issued a regulatory intimation regarding an upcoming group meeting with analysts and investors. The communication is addressed to both BSE Limited and the National Stock Exchange of India Limited.
The company will be interacting with investors and analysts through a virtual conference organized by Bharat Connect Arihant Capital. The meeting is scheduled for Monday, September 28, 2026, at 11:00 AM IST.
This intimation is made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company explicitly states that the discussion will be based solely on publicly available information, and no unpublished price-sensitive information will be shared during the meeting.
The meeting will reference the Investor Presentation for Q1FY27 (June 2027), which is already in the public domain and available on both the company's website and the stock exchanges' websites. The company notes that changes to the schedule may occur due to exigencies on the part of investors, analysts, or the company itself.
The document is signed by Ankur Sharma, Company Secretary and Compliance Officer (Membership No. A31833), and was digitally signed on September 21, 2026, at 15:19:20 IST.